C4 THERAPEUTICS INC (CCCC:NASDAQ)
$2.78 -0.28 (-9.1503%)
Analysed C4 THERAPEUTICS INC (CCCC:NASDAQ) News Sources
Is MacroGenics (MGNX) Stock Outpacing Its Medical Peers This Year?
09-10-2026
yahoo.com
C4 Therapeutics, Inc. (NASDAQ:CCCC) Just Reported And Analysts Have Been Lifting Their Price Targets
15-05-2026
yahoo.com
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18-05-2026
yahoo.com
C4 Therapeutics to Participate in Upcoming Conferences
20-05-2026
yahoo.com
C4 Therapeutics (CCCC) Upgraded to Buy: What Does It Mean for the Stock?
01-06-2026
yahoo.com
C4 Therapeutics Reports 53% Response Rate for Cemsidomide at RP2D
11-06-2026
yahoo.com
C4 Therapeutics, Inc. (CCCC) Is Up 2.65% in One Week: What You Should Know
03-07-2026
yahoo.com
C4 Therapeutics, Inc. (CCCC) Reports Q2 Loss, Tops Revenue Estimates
11-08-2026
yahoo.com
C4 Therapeutics to Present New Biomarker Data on the Immunomodulatory Effects of Cemsidomide in Combination with Dexamethasone from its Phase 1 Relapsed/Refractory Multiple Myeloma Trial at the 23rd International Myeloma Society (IMS) Annual Meeting
03-09-2026
yahoo.com
Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year?
23-09-2026
yahoo.com
What is the current price of C4 THERAPEUTICS INC (CCCC:NASDAQ)?
The current price of C4 THERAPEUTICS INC (CCCC:NASDAQ) is $2.78.
C4 THERAPEUTICS INC (CCCC:NASDAQ) absolute price change since previous trading day?
The absolute price change of C4 THERAPEUTICS INC (CCCC:NASDAQ) since the previous trading day is $-0.28.
C4 THERAPEUTICS INC (CCCC:NASDAQ) percentage price change since previous trading day?
The percentage price change of C4 THERAPEUTICS INC (CCCC:NASDAQ) since the previous trading day is -9.1503%.
What is the most recent average sentiment score for C4 THERAPEUTICS INC (CCCC:NASDAQ)?
The most recent average sentiment score for C4 THERAPEUTICS INC (CCCC:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for C4 THERAPEUTICS INC (CCCC:NASDAQ)?
The most recent sentiment for C4 THERAPEUTICS INC (CCCC:NASDAQ) is .
SEC-8K** Filing Available For C4 THERAPEUTICS INC (CCCC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.